4D Pharma

About:

4D Pharma PLC is a world leader in the development of live biotherapeutics.

Website: https://www.4dpharmaplc.com

Top Investors: Oxford Finance LLC

Description:

4D is a world leader in the development of live biotherapeutics, a novel and emerging class of drugs, defined by the FDA as biological products that contain a live organism, such as a bacteria, that is applicable to the prevention, treatment or cure of a disease. 4D has developed a proprietary platform, MicroRx, that rationally identifies novel bacteria that have a precise and evolved therapeutic effect. All of 4D's live biotherapeutic products are orally delivered single strains of bacteria that are naturally found in the healthy human gut. 4D currently has a pipeline of 15 therapeutic programmes covering autoimmune diseases, CNS disorders and cancer; with two programmes in patient trials, and the expectation to initiate another three programmes over the coming twelve months.

Total Funding Amount:

$53.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Aberdeen, Aberdeen City, United Kingdom

Founded Date:

2014-01-01

Founders:

Alexander Stevenson, Duncan Peyton

Number of Employees:

101-250

Last Funding Date:

2021-07-29

IPO Status:

Public

Industries:

© 2025 bioDAO.ai